“OVARIAN CYSTS AND HYPERESTROGENIA AS A SIDE EFFECT OF TAMOXIFEN THERAPY IN BREAST CANCER PATIENTS OF REPRODUCTIVE AND POSTMENOPAUSAL AGE”, Вопр. онкол., vol. 64, no. 1, pp. 88–94, Jan. 2018, doi: 10.37469/0507-3758-2018-64-1-88-94.